Literature DB >> 28210914

Comparison of histopathological characteristics of polyacrylate polyalcohol copolymer with dextranomer/hyaluronic acid after injection beneath the bladder mucosa layer: a rabbit model.

Abdol-Mohammad Kajbafzadeh1, Shabnam Sabetkish2, Reza Khorramirouz2, Nastaran Sabetkish2.   

Abstract

OBJECTIVES: To compare short- and long-term local tissue reaction of polyacrylate polyalcohol copolymer (PPC) with dextranomer/hyaluronic acid (DHA) in rabbits.
METHODS: Eight healthy New Zealand rabbits were randomly divided into two groups. In group I (control group), DHA was injected just beneath the mucosal layer of the bladder wall, while PPC was injected in group II. Subcutaneous injection of both bulking agents was also performed in nude mice. Histological evaluations with leukocyte common antibody (LCA), CD68, CD31, and CD34 were conducted on biopsies 1 and 6 months postoperatively. Scanning electron microscopy (SEM) and MTT assay were also performed for these two bulking agents.
RESULTS: SEM images revealed larger particle size of PPC. LCA and CD68 staining was significantly higher in group II as compared with group I in both short- and long-term follow-ups. However, in groups I and II, expression of CD31 (101 ± 0.5 vs. 92 ± 0.25, p > 0.05) and CD34 (115 ± 0.75 vs. 103 ± 0.5, p > 0.05) was not significantly different in long-term follow-up. Remarkably, severe fibrosis was observed in group II as compared to mild fibrosis in group I one month after injection. The results of in vivo application of these bulking agents in nude mice were in accordance with the results obtained from rabbit model. MTT assay revealed that cell proliferation was significantly higher in the presence of DHA as compared with PPC.
CONCLUSION: Severe inflammation and fibrosis in PPC may be due to continued foreign body reaction, presence of alcohol polymers, or larger particle sizes.

Entities:  

Keywords:  Animal model; Bulking agent; Deflux, dextranomer; Polyacrylate polyalcohol copolymer

Mesh:

Substances:

Year:  2017        PMID: 28210914     DOI: 10.1007/s11255-017-1540-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

1.  Treatment of vesicoureteric reflux by endoscopic injection of Teflon. 1984.

Authors:  Barry O'Donnell; P Puri
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

2.  Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux.

Authors:  David Ben-Meir; Sara Morgenstern; Bezalel Sivan; Rachel Efrat; Pinhas M Livne
Journal:  J Urol       Date:  2012-05-15       Impact factor: 7.450

Review 3.  Long-term results of endoscopic treatment of vesicoureteric reflux with different tissue-augmenting substances.

Authors:  Boris Chertin; Stanislav Kocherov
Journal:  J Pediatr Urol       Date:  2009-11-05       Impact factor: 1.830

4.  Endoscopic correction of primary VUR by using polyacrylate polyalcohol copolymer (Vantris) in young girls: 2-year follow-up.

Authors:  Farzaneh Sharifiaghdas; Farzam Tajalli; Hasan Otukesh; Rozita Hosseini Shamsabadi
Journal:  J Pediatr Urol       Date:  2014-04-05       Impact factor: 1.830

5.  Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents.

Authors:  Regina Johanna Franziska Stredele; Hans-Georg Dietz; Maximilian Stehr
Journal:  J Pediatr Urol       Date:  2011-12-31       Impact factor: 1.830

6.  Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.

Authors:  Katherine Moore; Stéphane Bolduc
Journal:  J Urol       Date:  2014-06-10       Impact factor: 7.450

7.  Preliminary data on endoscopic treatment of vesicoureteric reflux with polyacrylate polyalcohol copolymer (Vantris®): surgical outcome following single injection.

Authors:  Boris Chertin; Wael Abu Arafeh; Alexander Zeldin; Stanislav Kocherov
Journal:  J Pediatr Urol       Date:  2010-12-30       Impact factor: 1.830

8.  Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder.

Authors:  A M Stenberg; A Sundin; B S Larsson; G Läckgren; A Stenberg
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

9.  A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results.

Authors:  A Stenberg; G Läckgren
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

10.  Endoscopic correction of VUR using vantris as a new non-biodegradable tissue augmenting substance: three years of prospective follow-up.

Authors:  Boris Chertin; Wael Abu Arafeh; Alexander Zeldin; Israel A Ostrovsky; Stanislav Kocherov
Journal:  Urology       Date:  2013-03-07       Impact factor: 2.649

View more
  4 in total

Review 1.  Endoscopic injection therapy.

Authors:  Sang Woon Kim; Yong Seung Lee; Sang Won Han
Journal:  Investig Clin Urol       Date:  2017-06-02

Review 2.  Management of Vesicoureteral Reflux: What Have We Learned Over the Last 20 Years?

Authors:  Göran Läckgren; Christopher S Cooper; Tryggve Neveus; Andrew J Kirsch
Journal:  Front Pediatr       Date:  2021-03-31       Impact factor: 3.418

3.  New bulking agent for the treatment of vesicoureteral reflux: Polymethylmethacrylate/dextranomer.

Authors:  Sang Woon Kim; Yong Seung Lee; Young Jae Im; Sang Won Han
Journal:  Investig Clin Urol       Date:  2018-04-10

4.  Local tissue reaction and histopathological characteristics of three different bulking agents: a rabbit model.

Authors:  Shabnam Sabetkish; Mohammad Javad Mohseni; Nastaran Sabetkish; Abdol-Mohammad Kajbafzadeh
Journal:  Int Braz J Urol       Date:  2021 Mar-Apr       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.